Haemonetics | HAE - Cost Of Sales


Haemonetics reported $136.58M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.83B 8M Mar/2026
Cerus USD 23.42M 3.61M Dec/2024
Cooper Companies USD 376.8M 87.4M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.68B 38.37M Dec/2025
Globus Medical USD 290.47M 8.09M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Intuitive Surgical USD 940.3M 21.6M Mar/2026
Masimo USD 165.2M 24.3M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Neogen USD 112.2M 5.81M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
ResMed USD 555.85M 29.13M Dec/2025
STAAR Surgical USD 14.06M 2.8M Dec/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 9.49M 23.54M Jun/2025
Teleflex USD 261.54M 199.84M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
US Physical Therapy USD 160.86M 2.63M Dec/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025